MedMira, Inc. (CVE:MIR) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
MedMira, Inc.

BRIEF

published on 11/29/2025 at 03:05, 6 days 3 hours ago

MedMira Releases FY2025 Financial Performance

Financial Results MedMira Diagnostic Tests FY2025 MiROQ Technology
PRESS RELEASE

published on 11/29/2025 at 03:00, 6 days 3 hours ago

MedMira Reports FY2025 Fourth Quarter and Year End Financial Results
MedMira Inc. reports on financial results for FY2025, including product launches, clinical trials, and commercial advancements. Details on revenue, profit, loss, and balance sheet highlights are provided

Financial Results Clinical Trials MedMira Inc. Product Launches Commercial Advancements
BRIEF

published on 08/26/2025 at 22:48, 3 months 9 days ago

Health Canada Grants Approval for MedMira's Rapid Syphilis Test

Health Canada Syphilis MedMira Rapid Testing Infectious Disease
PRESS RELEASE

published on 08/26/2025 at 22:43, 3 months 9 days ago

Health Canada Approves MedMira's Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis
MedMira receives Health Canada approval for Reveal® TP (Syphilis) Antibody Test, the fastest standalone syphilis screening device in Canada. The test offers immediate results from a finger-prick blood sample, aiding in early detection and treatment

Clinical Trials Health Canada Approval MedMira Reveal TP Syphilis Screening
BRIEF

published on 07/07/2025 at 13:05, 4 months 28 days ago

MedMira Initiates Clinical Trial for Multiplo® TP/HIV Self-Test in Canada

Public Health Clinical Trial MedMira HIV And Syphilis Self-test
PRESS RELEASE

published on 07/07/2025 at 13:00, 4 months 28 days ago

MedMira Announces Launch of Clinical Trial for Its Multiplo(R) TP/HIV Self-Test in Canada
MedMira Inc. and REACH Nexus announce the start of a clinical trial for Multiplo® TP/HIV self-test in Canada to curb HIV and syphilis epidemics

MedMira Inc. Clinical Trial REACH Nexus Multiplo® TP/HIV Self-test
BRIEF

published on 07/01/2025 at 05:05, 5 months 4 days ago

MedMira's Q2 FY2025 Financials and Strategic Advances

Financial Results Clinical Trials Product Launch MedMira Q2 FY2025
PRESS RELEASE

published on 07/01/2025 at 05:00, 5 months 4 days ago

MedMira Reports Second Quarter Results FY2025
MedMira Inc., a Canadian biotech company, announces financial results and milestones achieved in Q3 FY2025, including new product launches and progress in clinical trials for HIV tests

Financial Results Clinical Trials MedMira Inc. Health Canada Approval HIV Tests
BRIEF

published on 04/17/2025 at 12:05, 7 months 17 days ago

MedMira and Lovell Partner to Expand Distribution of Reveal® G4 HIV Test

MedMira Rapid Vertical Flow Technology Reveal® G4 HIV Test Lovell Government Services Federal Healthcare Systems
PRESS RELEASE

published on 04/17/2025 at 12:00, 7 months 17 days ago

MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense
MedMira Inc. partners with Lovell Government Services to offer the world's fastest HIV rapid test in federal healthcare systems like VHA, MHS, and IHS. MedMira's Reveal G4 HIV test eliminates prozone effect for highly accurate results

MedMira Inc. HIV Rapid Test Lovell Government Services Federal Healthcare Systems Prozone Effect

1 2 ... 6

Accesswire

Published on 12/05/2025 at 02:35, 3 hours 41 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 3 hours 46 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 16 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 11 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 16 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 2 hours 45 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 25 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 50 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 1 minute ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 5 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 12 hours 16 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 31 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 31 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 15 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE